-TNF plays a crucial role in the pathogenesis of acute lung injury. However, the expression profile of its two receptors, p55 and p75, on pulmonary endothelium and their influence on TNF signaling during lung microvascular inflammation remain uncertain. Using flow cytometry, we characterized the expression profile of TNF receptors on the surface of freshly harvested pulmonary endothelial cells (PECs) from mice and found expression of both receptors with dominance of p55. To investigate the impact of stimulating individual TNF receptors, we treated wild-type and TNF receptor knockout mice with intravenous TNF and determined surface expression of adhesion molecules (Eselectin, VCAM-1, ICAM-1) on PECs by flow cytometry. TNFinduced upregulation of all adhesion molecules was substantially attenuated by absence of p55, whereas lack of p75 had a similar but smaller effect that varied between adhesion molecules. Selective blockade of individual TNF receptors by specific antibodies in wildtype primary PEC culture confirmed that the in vivo findings were due to direct effects of TNF receptor inhibition on endothelium and not other cells (e.g., circulating leukocytes). Finally, we found that PEC surface expression of p55 dramatically decreased in the early stages of endotoxemia following intravenous LPS, while no change in p75 expression was detected. These data demonstrate a crucial in vivo role of p55 and an auxiliary role of p75 in TNF-mediated adhesion molecule upregulation on PECs. It is possible that the importance of the individual receptors varies at different stages of pulmonary microvascular inflammation following changes in their relative expression.
CD120a and CD120b, or TNF receptor superfamily 1a and 1b, respectively) (62) . Historically, p55 has been considered as the major effector of TNF-mediated responses, with p75 proposed merely to enhance p55 signaling via "ligand-passing." This dogma may need reevaluation, as it is becoming clear that p75 can mediate cellular responses partly or completely independently from p55 (6, 31, 36, 62) . Moreover, it has been reported that the two receptors can even play directly opposing roles in some acute inflammatory conditions, including sepsis, retinal ischemia, and lung injury induced by high-stretch mechanical ventilation (17, 18, 22, 64) . Thus tissue-specific expression of each individual TNF receptor would play a major role in determining the inflammatory response of an organ to TNF stimulation. Indeed, cell-specific differential expression of TNF receptors has been proposed as being important in determining the outcome of heart transplant rejection (5) .
The majority of previous studies on the roles of each TNF receptor in endothelial cells have indicated that p55 receptor almost exclusively regulates TNF-induced inflammatory gene activation, such as adhesion molecule expression (35, 37, 47, 59, 67) , although such studies primarily utilized human umbilical vein endothelial cells (HUVEC) cultured in vitro. In direct contrast, Chandrasekharan et al. (10) observed an essential role for p75 in regulating TNF-induced expression of adhesion molecules in aortic endothelial cells. Such inconsistencies reflect the crucial importance of endothelial cell heterogeneity across the different vascular beds (4) , highlighting the danger of extrapolating findings obtained in HUVECs to endothelial cells in other tissues. The lung microvasculature, in particular, is known to be functionally and phenotypically distinct from most other vascular beds, in terms of the site and adhesion molecule requirements of leukocyte extravasation, for example (14) . While a small number of studies have attempted to investigate the specific role of pulmonary endothelial TNF receptors, they may be considered somewhat limited in terms of using either semiquantitative methodologies (20, 44) or cultured lung cells (26) . Cell culture often results in changes in the phenotype of primary cells, and, therefore, reconciliation of in vitro results with in vivo findings is essential to define the role of each TNF receptor during the activation of pulmonary endothelium. Thus the relative expression of each TNF receptor within the pulmonary circulation and their precise roles in pulmonary microvascular inflammation in vivo still remain unclear.
In this study, we established a flow cytometry-based technique to quantitatively evaluate for the first time in situ expression of TNF receptors and cell adhesion molecules on pulmonary endothelial cells (PECs), in lung single-cell suspensions freshly harvested from in vivo treated mice. These data show that p55 is dominant over p75 in terms of both expression and influence on TNF-induced adhesion molecule upregulation on PECs. However, the importance of individual receptors may vary during different stages of pulmonary microvascular inflammation following changes in their relative expression.
MATERIALS AND METHODS
Animals. All experimental protocols involving animals were approved by the Ethical Review Board of Imperial College London and carried out under the authority of the UK Home Office, in accordance with the Animals (Scientific Procedures) Act 1986. Experiments were performed using male wild-type C57/Bl6 mice, aged 9 -12 wk, or ageand sex-matched mice lacking p55 [p55 knockout (p55KO)], p75 (p75KO), or both [double knockout (DKO)] TNF receptors (generous gifts from Amgen, Thousand Oaks, CA) (50) .
Adhesion molecule expression on PECs in response to TNF in vivo. Wild-type or TNF receptor knockout mice were injected with 500 ng recombinant mouse TNF (R&D Systems Europe, Abingdon, UK) via tail vein. Two or four hours later, animals were killed by isoflurane overdose and exsanguinated by cardiac puncture, the lungs were excised, and a single-cell suspension was prepared for flow cytometric analysis of adhesion molecules. Untreated animals served as controls.
TNF receptor expression on PECs in vivo. Wild-type mice were killed, and 1 ml of ice-cold inhibitor cocktail was instilled through tracheostomy into the lungs to minimize TNF receptors shedding during lung tissue processing. The cocktail consists of serine/cysteine protease inhibitor (1 mM PMSF, Sigma-Aldrich, Poole, UK) and metalloprotease inhibitor (10 M BB94, British Biotech, Abingdon, UK) in PBS with 2% FCS, 1% sodium azide, and 5 mM EDTA. Lungs were then excised to prepare a single-cell suspension, and TNF receptor expression on PECs was assessed by flow cytometry. In a separate series of experiments, mice were injected with 20 g LPS (Ultra-pure LPS from E. coli O111:B4, Source BioScience UK, Nottingham, UK) via the tail vein. After 2, 4, 8, or 24 h, animals were killed, and the lungs processed as described.
Preparation of lung single-cell suspensions. Lung single-cell suspensions were prepared slightly differently, depending on whether adhesion molecule or TNF receptor expression was to be studied. For adhesion molecule expression, mechanical disruption and enzymatic digestion of excised lungs was carried out using an established technique, described and validated by our laboratory previously (46) . Briefly, after harvest, the lung was rinsed in saline and finely minced in a petri dish by manual chopping using a surgical blade. The tissue was resuspended in saline and incubated in 0.5 mg/ml collagenase (type IV, Sigma) at 37°C for 30 min. The resultant digest was then pushed through a 40-m nylon mesh sieve (BD Falcon, Oxford, UK) with a syringe plunger and flushed through using FACS wash buffer (2% FCS, 1% sodium azide, and 5 mM EDTA), to produce the single-cell suspension.
The tissue processing method was adapted slightly for assessment of TNF receptors. These molecules are highly sensitive to proteaseinduced shedding (much more so than adhesion molecules), and pilot experiments indicated that even a very short enzymatic digestion step had a major adverse effect on surface expression of the receptors. Therefore, to maximize cell yield while maintaining receptor expression, lungs were chopped (without collagenase, in the inhibitor cocktail described above) using a gentleMACS tissue dissociator (Miltenyi Biotec, Bisley, UK), after which they were also filtered and flushed through a sieve.
The lung single-cell suspension was finally centrifuged at 1,300 rpm for 7 min, the supernatant discarded, and the pellet resuspended. The samples were kept on ice throughout the procedure (except the short collagenase incubation period where utilized) until analyzed by flow cytometry.
Isolation and culture of primary PECs. Wild-type mice were killed, and 1 ml of 1 mg/ml dispase (Gibco, Invitrogen, Paisley, UK) was instilled through tracheostomy into the lungs and left for 5 min, after which lungs were excised and washed in HBSS (Sigma-Aldrich) containing 0.5% FCS. Samples were finely minced, digested in 1 mg/ml dispase at 37°C for 45 min, and then mechanically dissociated by triturating and filtered through a 40-m nylon mesh to form a single-cell suspension. PECs were isolated from the suspension by a magnetic labeling method, using the midiMACS separation unit (Miltenyi), according to the manufacturer's instructions. In brief, depletion of CD45 ϩ (pan-leukocyte marker) cells was followed by two repeated steps of enrichment of CD31 ϩ (PECAM-1, endothelial cell marker) cells. By this method, we could obtain 6 million PECs on average per mouse [determined by flow cytometry using microsphere counting beads (Caltag Medsystems, Towcester, UK)]. Cells were then cultured at 37°C in 5% CO 2 in DMEM supplemented with 1% nonessential amino acids (Sigma), 1% sodium pyruvate (Sigma), 12 U/ml heparin (Leo Laboratories, Princes Risborough, UK), 25 mM HEPES (VWR, Lutterworth, UK), 10% heat-inactivated FCS, 2 mM glutamine, 100 g/ml streptomycin, 100 U/ml penicillin (all from Gibco), and 50 g/ml endothelial cell growth supplement (Sigma) in flasks coated with 1% type B gelatin (Sigma). After overnight culture, cells were washed to remove nonadherent cells, and fresh medium was added. Once the cells reached confluence, they were replated using trypsin-EDTA (Sigma) and used for experiments between passages 3 and 8.
Adhesion molecule expression on PECs in response to TNF in vitro. Cultured PECs were seeded at a density of 10 5 cells/well in a 24-well plate coated with 1% type B gelatin. After overnight culture, the medium was replaced with RPMI containing 10% FCS, and triplicate wells were allocated into one of four groups: no treatment (control); 10 ng/ml recombinant mouse TNF for 4 h; and preincubation with anti-p55 (90 g/ml; 55R-170, BD Biosciences) or anti-p75 (20 g/ml; TR75-32, BD Biosciences) neutralizing antibody for 1 h before TNF treatment. The anti-TNF receptor antibodies are validated by the manufacturer as having no cross-reactivity between receptor subtypes. Cells were recovered/detached with 1% trypsin-EDTA at 37°C for 1 min and processed for flow cytometry.
Flow cytometry. In both the in vivo and in vitro studies, experiments were first carried out to characterize phenotype of PECs. Cell samples were stained in the dark on ice for 30 min with fluorophoreconjugated anti-mouse antibodies for general endothelial cell markers PECAM-1 (CD31, clone MEC13.3), Endoglin (CD105, MJ7/18), VE-cadherin (CD144, BV13), and ICAM-2 (CD102, 3C4), capillary/ microvascular markers Mucosialin (CD34, RAM34) and Griffonia simplicifolia lectin, and their appropriate controls (i.e., isotype or unstained). Antibodies were all from BD Biosciences, apart from Griffonia simplicifolia lectin (Sigma). For TNF receptor expression, samples were stained for PECAM-1 and for TNF receptor p55 (55R-286), p75 (TR75-89), and their isotype controls (AbD Serotec, Kidlington, UK). For adhesion molecule expression, samples were stained for PECAM-1 and for VCAM-1 (CD106, 429), ICAM-1 (CD54, 3E2), and E-selectin (CD62E, 10E9.6) and their isotype controls (antibodies all from BD Biosciences). Samples were analyzed using a FACSCalibur flow cytometer (BD) and FlowJo software (Tree Star, Ashland, OR). Expression levels of TNF receptors and adhesion molecules were assessed on PECs (defined as the high PECAM ϩ cells, at least 2,000 gated events in each analysis), expressed as mean fluorescence intensity after subtraction of isotype control values.
Statistical analysis. Data are expressed as means Ϯ SD. Statistical comparisons were made by ANOVA with Bonferroni tests or by t-tests. A value of P Ͻ 0.05 was considered as significant.
RESULTS

Basal expression of p55 and p75 receptors on PECs.
To clarify the expression of individual TNF receptors on PECs in vivo, we developed a quantitative flow cytometry technique to assess the expression of the two receptor subtypes in single-cell suspensions freshly prepared from the excised lungs of mice. Endothelial cells were identified as PECAM-1 high events on the dot plot, which consistently displayed positive expression of endoglin (CD105), VE-cadherin (CD144), and ICAM-2 (CD102), confirming the endothelial origin of these cells (Fig. 1A) . Additionally, cells were stained for mucosialin (CD34) and the lectin Griffonia simplicifolia. Positive staining for both of these markers suggests that the vast majority of endothelial cells analyzed were microvascular in origin (32, 43, 56) , although some contamination by macrovascular cells cannot be entirely excluded.
Under resting conditions, both the p55 and p75 receptors were expressed on PECs, with significantly greater expression for p55 compared with p75 (Fig. 1B) . To confirm that the relative level of expression of the individual receptors was not due to differential susceptibility to shedding during cell harvest and processing, we determined TNF receptor levels on endothelial cells harvested from the liver using the same tissue processing methodologies. On these cells, we found that p55 expression was similar to that found on pulmonary endothelia, but p75 expression was much greater, indicating that tissue processing artifacts did not explain the relative expression levels (Fig. 1C) . As a final validation of the flow cytometry technique, TNF receptor expression was also assessed on PECs from genetically modified animals lacking TNF receptors (Fig.  1D) . The p55 signal was completely absent in the p55KO mice, while the p75 signal was effectively nil in the p75KO animals with a very small degree of nonspecific staining with this antibody, demonstrating that low-level p75 expression on wildtype PECs was indeed an authentic signal. The histograms of p55 or p75 staining in wild-type animals are consistent with the pattern of normal distribution, suggesting that all PECs are expressing a moderate (p55) or low (p75) level of receptors, with no evidence of subpopulations of positive and negative cells.
p55 and p75 TNF receptors both influence upregulation of adhesion molecules on PECs in vivo.
Having identified both p55 and p75 receptors on the surface of PECs, we then attempted to dissect the specific roles of the receptors in pulmonary endothelial activation. Wild-type and TNF receptor knockout mice were treated with intravenous (iv) TNF, and the surface expression of leukocyte adhesion molecules VCAM-1, E-selectin, and ICAM-1 was quantitatively assessed on PECs by flow cytometry. Although these cells were harvested using a slightly modified technique compared with the TNF receptor expression studies (i.e., inclusion of a short collagenase digestion step), we confirmed that they had the same phenotypic characteristics, i.e., positive expression of ICAM-2, VE-cadherin, and endoglin (not shown). Although it is possible that such a short warming period during the cell isolation procedure (i.e., collagenase digestion) could induce nonspecific effects on PECs, pilot studies indicated that these were negligible, at least with regards to adhesion molecule expression (not shown). In preliminary time course experiments using wild-type mice, E-selectin showed peak expression on PECs at 2 h after TNF treatment, while VCAM-1 and ICAM-1 expression was greater at 4 h (data not shown). Subsequent experiments compared E-selectin expression between strains at 2 h, and VCAM-1 and ICAM-1 expression at 4 h.
VCAM-1 had a moderate basal expression on PECs from all mouse strains, which was somewhat variable, although no strain was significantly different compared with wild types (Fig. 2A) . Surface expression was substantially upregulated upon TNF treatment in wild-type mice. Expression of VCAM-1 following stimulation was reduced in p75KO animals compared with wild-type mice and decreased to an even greater extent in p55KO and DKO mice. Unlike VCAM-1, E-selectin was not expressed under resting conditions (Fig. 2B) , but it was induced in wild-type mice upon iv TNF treatment. E-selectin expression tended to be reduced (although not significantly) in p75KO animals compared with wild types, whereas both strains of mice lacking the p55 receptor (i.e., p55KO and DKO) showed effectively zero expression. In contrast to VCAM-1 and E-selectin, ICAM-1 is expressed on PECs at a relatively high basal level in all strains (Fig. 2C ) and was upregulated further after TNF treatment in wild-type mice. While absence of the p75 receptor caused some tendency to decreased ICAM-1 expression, this was not significant. In contrast, mice lacking the p55 receptor (p55KO and DKO animals) expressed significantly less ICAM-1 after TNF stimulation compared with wild types.
Differences in adhesion molecule expression are due to TNF receptor signaling specifically on PECs. The in vivo data demonstrated that lack of p55 receptor signaling influenced TNF-induced adhesion molecule upregulation on PECs to a much greater extent than that of p75. To clarify that our in vivo findings reflect the importance of TNF receptors on "endothelial cells" per se, rather than an indirect consequence of TNF receptors signaling on other cells [e.g., leukocytes, which are known to activate PECs in a TNF-dependent manner (46)], we took an in vitro approach utilizing acute receptor blockade. For this purpose, PECs were isolated from wild-type mice and cultured and then treated with TNF in the presence or absence of a vast excess of neutralizing antibody for p55 or p75 receptors, and surface expression of adhesion molecules was quantified by flow cytometry as in vivo. Isolation of PECs by this method resulted in 95% purity of PECAM-1 ϩ cells (Fig. 3A) . Before each set of experiments, cells were stained for various endothelial cell markers, to confirm both that they still retained their phenotype across passages, and that measurement of adhesion molecule expression did not include the presence of any contaminating nonendothelial cells (Fig. 3B) .
Consistent with the in vivo findings, p75 blockade resulted in significant reduction of TNF-induced VCAM-1 and Eselectin expression by 28 and 23%, respectively (P Ͻ 0.05), but had no significant effect on ICAM-1 (Fig. 4A) . On the other hand, as with in vivo experiments, p55 blockade significantly decreased the expression of all adhesion molecules (P Ͻ 0.01) (Fig. 4B) .
p55 Receptor expression decreases, while p75 remains stable, during acute endotoxemia. Finally, we determined the influence of acute inflammation on the relative levels of TNF receptor expression. Historically, it is reported that p75 is more readily upregulated than p55 on stimulation (20, 26, 27) , while both receptors also show a propensity to be shed on cellular activation (15, 54, 61) . However, such data almost exclusively relate to primary leukocytes or leukocytic cell lines. Following iv LPS administration, we found that p75 expression on PECs did not change substantially over the following 24 h. In marked contrast, there was a substantial decrease of p55 expression at 2 h after LPS, which started to recover by 4 h and reached ϳ80% of baseline levels by 24 h (Fig. 5) . 
DISCUSSION
In this study we investigated for the first time the quantitative expression profile of TNF receptors on the surface of freshly harvested mouse PECs using flow cytometry and elucidated their roles in mediating TNF-induced expression of adhesion molecules as surrogate markers of endothelial activation. We found that, under resting conditions, both receptors are expressed on PECs, with p55 expressed at substantially higher levels than p75. Both receptors played some role in mediating TNF-induced expression of adhesion molecules, although the p55 receptor had a much greater impact than the p75 receptor in vivo. Finally, we demonstrated that acute endotoxemia induced a rapid downregulation of p55 expression on PECs, but no change in p75, which may have important consequences for TNF signaling during pulmonary microvascular inflammation.
Although TNF plays an indisputable role in sepsis/ALI (9, 25, 40, 41, 48) , blockade of total TNF signaling using anti-TNF antibodies is clinically not effective (1-3, 11, 21) , suggesting more complex mechanisms in TNF-mediated responses during sepsis/ALI than originally considered. Our laboratory previously demonstrated a novel role for differential TNF receptor signaling in ALI induced by mechanical stretch (64) and acid aspiration (49) . Using TNF receptor knockout mice, we found that signaling through p55 receptor promoted the development of pulmonary edema and respiratory failure, whereas signaling through TNF receptor p75 opposed this. Such differential signaling through the two TNF receptors has been observed in other acute inflammatory conditions (17, 18, 22, 29) , indicating that the relative expression of the two receptor subtypes within the lung is critically important in determining the consequences of TNF signaling during the course of ALI.
Most of our current understanding of TNF receptor expression on endothelial cells comes from HUVEC data, where TNF binding studies suggest that p55 is marginally the dominantly expressed receptor (47, 53, 60) , while flow cytometric analysis showed similar or slightly higher expression of p75 (37, 59) . The expression on endothelial cells in the pulmonary microvasculature is not clear. Previous studies suggested relatively similar expression of p55 compared with p75 on PECs of rats ϩ cells by a magnetic labeling method, using the midiMACS separation unit. This provided a 95% purity of PECs for culture. Dot plots represent composition of cell suspension before and after CD45 ϩ cell depletion and after PECAM-1 ϩ cell enrichment. B: before experiments (as well as at time of purification), PECAM-1 ϩ cells were characterized by staining for endoglin, VE-cadherin, and ICAM-2 to ensure their endothelial phenotype was maintained from passage to passage. Staining with the respective antibody (solid line) and isotype control (shaded fill) is shown on histograms in passage 6 cells. FSC, forward scatter. and humans, although these findings rely on data from prolonged in vitro cultures (26) and semiquantitative methods, such as immunohistochemistry (20) . Therefore, quantitative in vivo analysis of TNF receptors on PECs has been lacking.
To address this, we established a flow cytometry method that enabled us to quantitatively evaluate the receptor expression on PECs in a single-cell suspension. Positive cell staining for a panel of endothelial cell markers, including mucosialin and Griffonia simplicifolia lectin, suggest that the PECs analyzed were primarily microvascular in origin. This distinction is potentially important, as phenotypic and functional heterogeneity has been described among PECs of microvascular and macrovascular origin (24, 32, 65) . Using a mixture of protease inhibitors and keeping the working temperature close to 4°C, we attempted to minimize loss/shedding of the receptors during the lung processing and analysis procedures. In untreated mice, we found that both TNF receptors were expressed on PECs, with p55 expression substantially higher than that of p75. By the use of knockout mice, we were able to demonstrate that the antibody binding was indeed specific to each receptor, with only a small nonspecific signal for p75. We also measured the relative expression of TNF receptors on endothelial cells harvested from the liver using the same techniques and found that, while p55 expression was similar to that found in PECs, p75 expression was greater, exceeding the levels of p55. These data strongly support that the low signal of p75 on PECs is not due to processing artifacts and, more importantly, highlight the potential risks of extrapolating between endothelial cells from different sources.
A previous in vivo study by Neumann et al. (44) using knockout mice suggested a crucial role of p55 in TNF-induced expression of E-selectin and VCAM-1 (measured by immunohistochemistry) and recruitment of leukocytes within the lung, although this study lacked investigation into any involvement of p75. To clearly dissect out the roles of the receptor subtypes, we injected TNF iv to wild-type mice or mice lacking one or both of the TNF receptors and quantitatively evaluated Eselectin, VCAM-1, and ICAM-1 expression on PECs using flow cytometry. We found that p55 receptor signaling was necessary for each adhesion molecule upregulation (in agreement with the study by Neumann et al.), while p75 signaling contributed to VCAM-1 upregulation, but any effects on Eselectin and ICAM-1 expression were less clear. To further clarify our observations from genetically modified mice, we used in vitro receptor blockade experiments. We found that the consequences of individual TNF receptor signaling observed in vivo were very likely due to direct effects on PECs and confirmed that p75 signaling influenced VCAM-1 and Eselectin expression. The influence of p75 signaling on ICAM-1 was less clear, which may indicate some differential effect of p75 on the different adhesion molecules, or reflect a relative lack of sensitivity as a result of the much higher basal expression of ICAM-1.
Our findings indicating a minor role for p75 in TNFmediated adhesion molecule expression may be consistent with the ligand-passing theory of TNF signaling on PECs, whereby p75 functions primarily to modulate signaling through p55. Alternatively, it could be a reflection of the relative level of receptor expression (i.e., p55 Ͼ p75) on PECs, and p75 may be more important in other organ beds (e.g., liver) or conditions, where the relative expression of the receptors are changed. For example, our finding that the p75 receptor does not contribute much to ICAM-1 upregulation contrasts with a previous report by Chandrasekharan et al. (10) . Using aortic endothelial cells from TNF receptor knockout animals, they reported that p75 receptor signaling was greatly responsible for ICAM-1 expression, although they did not assess the relative levels of TNF receptor expression on their cells. This suggests that the role of p75 in signaling varies between vascular beds, which would tend to argue against a generalized ligand-passing concept for this receptor.
Expression of the TNF receptors is regulated by protein synthesis, both at the transcriptional/translational level, by the action of sheddases, such as TNF-␣ converting enzyme (33, 57, 62) and by internalization mechanisms (28) . Both p55 and p75 may be shed or internalized from the surface of cells, and under certain circumstances both can be upregulated, p75 more dynamically than p55 (13, 15, 16, 28, 30, 61) . However, the vast bulk of this knowledge comes from hematopoietic cells and cancer cell lines, which may not be applicable to endothelial cells. To assess the changes in TNF receptor expression on PECs following an inflammatory stimulus, we treated mice with LPS and determined the expression of the two receptors over 24 h. For the first time in freshly harvested PECs, we showed that surface p75 expression was effectively unchanged, while expression of the p55 receptor decreased greatly following LPS. Such a loss of surface p55 is likely to represent a regulatory mechanism to limit ongoing stimulation of the receptors following the initial ligand-receptor interaction. Indeed, TNF-induced TNF receptor shedding leading to deactivation of cells has been observed and investigated extensively in leukocytes (15, 55, 58) , and impaired shedding of p55 leads to an exaggerated inflammatory state in humans and mice (39, 66) . Although mice lacking the p55 receptor show attenuation in pulmonary neutrophil accumulation following systemic LPS challenge (8) , suggesting that TNF likely signals through the p55 receptor before shedding occurs, the subsequent downregulation of p55 receptors on endothelial cells may have significant long-term consequences (e.g., endothelial hypore- sponsiveness to further TNF stimuli) beyond the effect on adhesion molecules that we observed here.
Our findings regarding the changes in TNF receptor expression during inflammation are apparently inconsistent with those reported by Grau et al. (26) investigating the functional characteristics of PECs isolated from lungs of patients who died with acute respiratory distress syndrome. They demonstrated greater p75 expression on PECs from the patients than controls, which appeared to positively correlate with the duration of the disease, while no difference in p55 was observed. However, their study investigated TNF receptor expression on PECs in vitro after 2-to 3-wk culture, which may not reflect the phenotype at the time of isolation. Both our study and that by Grau et al. do, however, indicate a change in the ratio of p55 to p75 receptors on PECs during ALI/inflammation. The downstream consequences of such changes in the p55-to-p75 expression ratio remain unclear. As the present data indicate that p75 plays a similar role to p55 signaling in regards to adhesion molecule upregulation (albeit of lesser magnitude), it may be concluded that a relative shift in the contribution of signaling through p75 vs. p55 would have little impact. However, adhesion molecule upregulation is but one consequence of TNF receptor activation, and it is now clear that the two TNF receptors are able to signal independently. For example, TNF has been shown in neurons to mediate proapoptotic signaling through p55, but antiapoptotic signaling through p75 (38) . Changes in the relative levels of TNF receptor expression may, therefore, have substantial consequences not apparent from the present observations.
In more complicated models than used currently, our laboratory previously found that p75 signaling opposed, rather than complemented, that of p55 during the development of high stretch-induced pulmonary edema (64) . We consider that any apparent discrepancy between the present study and our laboratory's previous findings is likely to be a reflection of the relative complexity of the models and the parameters being investigated. The present study evaluated a single TNF-mediated response in a specific cell type (i.e., pulmonary endothelial adhesion molecule expression in response to iv TNF). In contrast, the previous study represented a much more complex effect of TNF receptor signaling on various pathophysiological processes during full-blown ALI models, involving endothelial/epithelial cell permeability (34, 45, 51, 52) and fluid reabsorption (7, 19, 23) . One possible interpretation is that the "protective" role of p75 signaling observed in our laboratory's previous study is not related to endothelial cell adhesion molecule upregulation (as we found p75 signaling plays a similar "injurious" role to that of p55, albeit less potent), although it is not certain that various ALI models cause injury in similar ways.
In summary, the present study provides invaluable new data of individual TNF receptor expression and signaling on pulmonary endothelium in vivo, by quantitative assessment of TNF receptors and TNF-induced expression of adhesion molecules on freshly harvested PECs using flow cytometry. The results highlight the potential risks in extrapolating data obtained in cell lines/endothelial cells from other vascular beds or using semiquantitative methods. Our findings add crucial pieces of information to our knowledge base of endothelial cell biology within the lung, which would lead to novel insights into TNF-mediated pathophysiology within the pulmonary microvasculature. Further work needs to be carried out to elucidate the functional consequences of individual TNF receptor signaling during pulmonary inflammation.
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